Search Results - "Millis, J.M."

De Novo Sirolimus and Reduced‐Dose Tacrolimus Versus Standard‐Dose Tacrolimus After Liver Transplantation: The 2000–2003 Phase II Prospective Randomized Trial by Asrani, S. K., Wiesner, R. H., Trotter, J. F., Klintmalm, G., Katz, E., Maller, E., Roberts, J., Kneteman, N., Teperman, L., Fung, J. J., Millis, J. M.

“…We studied whether the use of sirolimus with reduced‐dose tacrolimus, as compared to standard‐dose tacrolimus, after liver transplantation is safe, tolerated…”
Get full text

Improved Coating of Pancreatic Islets With Regulatory T cells to Create Local Immunosuppression by Using the Biotin-polyethylene Glycol-succinimidyl Valeric Acid Ester Molecule by Gołąb, K, Kizilel, S, Bal, T, Hara, M, Zielinski, M, Grose, R, Savari, O, Wang, X.-J, Wang, L.-J, Tibudan, M, Krzystyniak, A, Marek-Trzonkowska, N, Millis, J.M, Trzonkowski, P, Witkowski, P

“…Abstract Background We showed that T regulatory (Treg) cells can be attached to the surface of pancreatic islets providing local immunoprotection. Further…”
Get full text

Donor Height in Combination With Islet Donor Score Improves Pancreas Donor Selection for Pancreatic Islet Isolation and Transplantation by Wang, L.J, Cochet, O, Wang, X.J, Krzystyniak, A, Misawa, R, Golab, K, Tibudan, M, Grose, R, Savari, O, Millis, J.M, Witkowski, P

“…Abstract To maximize the islet isolation yield for successful islet transplantation, the key task has been to identify an ideal pancreas donor. Since…”
Get full text

829 SAFETY AND EFFICACY OF THE EXTRACORPOREAL LIVER ASSIST DEVICE (ELAD®) IN PATIENTS WITH ACUTE ON CHRONIC LIVER FAILURE by Hillebrand, D.J, Frederick, R.T, Williams, W.W, Brown, R.S, Napotilano, L.M, Te, H.S, Millis, J.M, Ashley, R.A, Pockros, P.J

Get full text

2007: The Year of Regulatory Change by Millis, J.M, Huang, J, Millis, M.A, Liu, Y, Mao, Y, Simmerling, M

“…Abstract Introduction The two countries that performed the most organ transplants in 2006, the United States and China, initiated significant regulatory…”
Get full text

Transmission of Human Immunodeficiency Virus and Hepatitis C Virus From an Organ Donor to Four Transplant Recipients by Ison, M. G., Llata, E., Conover, C. S., Friedewald, J. J., Gerber, S. I., Grigoryan, A., Heneine, W., Millis, J. M., Simon, D. M., Teo, C.‐G., Kuehnert, M. J.

“…In 2007, a previously uninfected kidney transplant recipient tested positive for human immunodeficiency virus type 1 (HIV) and hepatitis C virus (HCV)…”
Get full text

Liver and Vascularized Posterior Rectus Sheath Fascia Composite Tissue Allotransplantation by Agarwal, S., Dorafshar, A. H., Harland, R. C., Millis, J. M., Gottlieb, L. J.

“…Abdominal wall closure in pediatric solid organ recipients may be confounded by donor size discrepancy and structural insults from previous surgery. Here we…”
Get full text

LOP37: EXPANDING THE ENVELOPE: THE PORSH-LIVER VASCULAR COMPOSITE ALLOGRAFT by Lee, J.C., Olaitan, O., Lopez-Soler, R., Miller, M., Witkowski, P., Renz, J., Millis, J.M., Gottlieb, L.J.

Get full text

Acute Humoral Rejection in an ABO Compatible Combined Liver–Kidney Transplant—The Kidney Is Not Always Protected by Reichman, T. W., Marino, S. R., Milner, J., Harland, R. C., Cochrane, A., Millis, J. M., Testa, G.

“…Combined liver–kidney transplantation has become a common practice for the treatment of patients with concurrent end‐stage renal disease and end‐stage liver…”
Get full text

Dynamic assessment of oxygen content and isolation quality of pre-oxygenated solutions used for pancreatic preservation in islet transplantation by Zhao, P.X., Shen, J., Skarbek, R., Millis, J.M., Garfinkel, M.R.

“…Little is known about mechanism of action of pre-oxygenated University of Wisconsin solution (UW) over perfluorodecalin (PFD) in enhancing islet yield after…”
Get full text

5Is adult to adult live donor liver transplantation ethical? by Cronin, D.C., Millis, J.M., Siegler, M.

Get full text

Islet isolation under cGMP conditions: replacing the coil by Garfinkel, M.R, Connors, M, Ostrega, D, Jarosz, J, Philipson, L, Millis, J.M

“…Clinical islet transplantation is increasingly regulated, with isolation standards defined under current good manufacturing practices (cGMPs). cGMP requires…”
Get full text

ELAD: Report of cellular function during and after patient therapy by Millis, J.M., Cronin, D.C., Conjeevaram, H., Faust, T., Charette, J., Johnson, R., Conlin, C., Brotherton, J., Triglia, D., Maguire, P.

Get full text

Long-term outcome of patients undergoing OLT for hepatitis B-related liver disease without HBIG prophylaxia by Rinella, M.E., Dasgupta, K., Schiano, T.D., Lissoos, T.W., Millis, J.M., Baker, A.L., Conjeevaram, H.S.

Get full text

Corticosteroid Cessation 1 Week Following Renal Transplantation Using Tacrolimus/Mycophenolate Mofetil Based Immunosuppression by Grewal, H.P, Thistlethwaite, J.R, Loss, G.E, Bruce, D.S, Siegel, C.T, Cronin, D.C, Newell, K.A, Millis, J.M, Woodle, E.S

Get full text

Bioartificial liver support: report of the longest continuous treatment with human hepatocytes by Millis, J.M, Cronin, D.C, Johnson, R, Conjeevaram, H, Faust, T.W, Trevino, S, Conlin, C, Brotherton, J, Traglia, D, Maguire, P, Dane, G

Get full text

The impact of donor factors on the outcomes following liver transplantation by Buell, J.F, Cronin, D.C, Blahnik, L, Lo, A, Trimbach, C, Layman, R, Millis, J.M

Get full text

7Clinical impact of incidental compared to known hepatomas after ortotopic liver transplantation? by Buell, J.F., Yoshida, A., Kim, G., Layman, R., Hart, J., Swanson, A., Conjeevarum, H., Baker, A., Cronin, D.C., Millis, J.M.

Get full text

132Liver transplantation for pediatric liver tumors by Buell, J.F., Yoshida, A., Limscimchrem, S., Kelley, S., Boone, P., Trimbach, C., Brady, L., Cronin, D.C., Millis, J.M.

Get full text

20 A prospective trial of randomized veno-veno bypass in orthotopic liver transplantation: Preliminary data by Buell, J.F., Kulkami, S., Yoshida, A., Kopelan, A., Siegel, C.T., Woodle, E.S., Newell, K.A., Thistlethwaite, J.R., Millis, J.M., Bruce, D.S.

Get full text